Abstracts 12 y.o.), 55.4% were women. The average cost person/year was euro 3502.87; 73.9% attributable to hospitalisations, 17.5% to drugs, 8,6% to other medical costs. The 32.8% patients died during the follow up period, with a mean age of 84 ± 9 statistically different (p < 0.0001) from survivors (mean age 74 ± 11 y.o.). CONCLUSIONS: Stroke imposes a large social and economic burden on NHS and society because of the large number of hospitalisation and the high rate of mortality. Future investigations will be conduct to asses the relationships between comorbidity, costs, drug therapy and survival.
Chang Gung Memorial Hospital, Kaohsiung County, Taiwan OBJECTIVES: To assess factors influencing acute hospitalization for patients with first-ever ischemic stroke in Taiwan. METHODS: Data were prospectively collected from 360 firstever ischemic stroke patients consecutively admitted to a medical center within 48 hours after symptom onset. Longer stay was defined as length of stay (LOS) >7 days after admission in department of neurology for acute care. The association between demographic characteristics or clinical variables and LOS was examined using multivariate logistic regression analysis. Discrimination of the model was assessed by the area under the receiver operating characteristic curve, and calibration was assessed using goodness of fit test. RESULTS: Patients (58% male) had mean age 64.9 ± 12.7 (range, 18 to 93) years. Median National Institutes of Health Stroke Scale (NIHSS) score at admission was 6 (25th to 75th percentile, 3 to 12), median modified Barthel Index (MBI; on a scale of 0 to 20) at admission was 12 (25th to 75th percentile, 5 to 16). The LOS was >7 days in 169 (47%) patients. Male sex (odds ratio [OR], 1.7; 95% CI, 1.0 to 2.8), baseline NIHSS score 7-15 (versus 0-6) (OR, 2.9; 95% CI, 1.5 to 5.7), baseline NIHSS score ≥16 (versus 0-6) (OR, 3.1; 95% CI, 1.3 to 7.4), baseline MBI ≥12 (OR, 0.5; 95% CI, 0.3 to 1.0), and small vessel occlusive subtype (OR, 0.35; 95% CI, 0.2 to 0.6) were independent predictors of longer stay. Goodness-of-fit test (Hosmer-Lemeshow test) was not significant (P = 0.49), indicating adequate fitness. The model's discrimination was adequate with an under the curve area (receiver operating characteristic curve) of 0.776. CONCLUSIONS: The impact of stroke severity need to be understood to manager LOS. Early supported discharge planning would probably reduce the LOS in acute hospitalization of this group of first-ever ischemic stroke patients. using the MeSH terms anticoagulants, AF, warfarin and cerebrovascular disorder (prevention and control). Practicebased studies reporting the proportion of patients eligible to receive warfarin (i.e., no contraindications to thromboprophylaxis and at moderate or high risk of stroke) who actually received warfarin for stroke prevention in AF were retrieved. RESULTS: Twenty-one practice-based studies were found, of which 3 were excluded because the patient population or centre/setting significantly varied from the other identified studies. Approximately 47-89% of patients enrolled in the remaining 18 studies were eligible for stroke prevention. Only 15-64% of eligible patients received warfarin and 15-56% did not receive any form of stroke prevention therapy at all (i.e., no warfarin or antiplatelet agent). CONCLUSIONS: Despite the publication of multiple clinical trials and practice guidelines supporting the use of warfarin for stroke prevention in AF, many eligible patients do not receive appropriate preventive therapy, and therefore remain at increased risk of stroke. Reasons for the sub-optimal use of warfarin for stroke prevention in AF require further research.
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PST8 WARFARIN PATIENT SEGMENTS: GENERAL PRACTITIONERS VERSUS SPECIALISTS
Liovas AM AstraZeneca, Mississauga, ON, Canada OBJECTIVES: There is a documented lack of treatment and undertreatment with warfarin in AF patients. GPs and Specialists (SPs) may take different approaches to anticoagulation for their AF patients. The objective is to identify, compare and quantify warfarin patient segments for both SPs and GPs. METHODS: Physicians from Toronto, Montreal and Vancouver, randomly recruited from lists of high warfarin prescribers, participated in 60 minute qualitative interviews. Thirty-Six physicians were interviewed (14 GPs, 8 Cardiologists, 6 Internists and 3 Haematologists). RESULTS: SPs placed patients in 3 major segments: untreated (5% of their patients), treated (90-95%) and undertreated (5%). GPs had only 2 segments: untreated (10-25%) and treated (75-90%). Both physician groups identified untreated patients as those at risk of falling, demented, prone to bleed, immobile or refusing treatment. SPs referred to undertreated patients as those using ASA. GPs saw ASA users as part of their treated group. The other segment within the GP treated group was warfarin users. SPs divided their treated segment into well-controlled and not well-controlled. CONCLUSION: SPs and GPs use similar criteria in determining which patients do not receive warfarin. However, views on the value of ASA seem different. Further, GPs in this study did not distinguish between well and not-well controlled warfarin, but rather indicated ASA vs. warfarin users are both considered treated. Further research is required to further investigate the differences in opinion, lack of treatment and to quantify each segment. The SIS, a stroke-specific outcome measure, assesses 8 domains: strength (4 items), memory (7 items), emotion (9 items), communication (7 items), activities of daily living/instrumental activities of daily living (ADL/IADL) (10 items), mobility (9 items), hand function (5 items), and participation (8 items). SIS was translated and back-translated according to the standardized guidelines for cross-cultural adaptation. Patients consecutively admitted with ischemic stroke were recruited, until 30 patients in each of three groups of stroke severity were reached. Stroke severity was evaluated with NIH stroke scale and categorized as mild (0-6), moderate (7-15), or severe (16-38). Patients were assessed 3 times, within 7 days of admission, 3 months and 6 months afterwards. Ten randomly selected patients were re-administered 2 weeks after first administration for test-retest study. RESULTS: We studied 50 mild, 36 moderate, and 33 severe stroke patients. Cronbach's alpha was high for 6 domains (0.95 to 0.98), moderate for emotion (0.69) and participation (0.77). Intraclass correlation coefficients ranged from 0.63 to 0.89, except for memory (0.13), hand function (0.47), and ADL/IADL (0.53). Based on first assessment, memory and communication may have potential for ceiling effects in mild stroke group, strength and hand function may have potential for floor effects in moderate stroke group, and all domains may have potential for floor/ceiling effects in severe stroke group. The correlations between each of the physical domains (strength, ADL/IADL, mobility, hand function) and Barthel Index were good (0.72 to 0.92). Memory domain showed a high correlation with MMSE (0.81).
CONCLUSIONS:
The Mandarin version of the SIS is an acceptable stroke-specific outcome measure in most domains. Further studies in determining the content should enhance confidence in its validity. AstraZeneca, Mississauga, ON, Canada OBJECTIVES: To present steps involved in launching the first national, prospective study determining resource utilization and direct (hospitalization, rehabilitation, outpatient, community care) and indirect (lost productivity, caregiver) costs of managing ischemic stroke in the first 6-months post-stroke. METHODS: A prospective, observational study was designed. A cohort (N = 200) of ischemic stroke patients will be recruited in a consecutive manner by stroke centres across Canada. Ethics approvals will be obtained and a minimum of one neurologist and one study coordinator per centre will participate to identify eligible patients, obtain informed consent, and interview patients. Three sets of questionnaires (baseline, 3-months, and 6-months) will be completed. Questionnaires include clinical and drug histories, stroke severity, disability, resource utilization, depression and utility. Patients will also complete diaries to quantify indirect costs. A pilot study will be conducted to evaluate the study tools. Data collected will be entered electronically via a secure website. RESULTS: Ten stroke centres across Canada (Ottawa, Toronto, Calgary, Montreal, Quebec City, Edmonton, Vancouver, Halifax, Saint John and Thunder Bay) will each recruit 20 eligible ischemic stroke patients into this study. Inclusion criteria such as age, language, neuroimaging evidence and non-interventional clinical trial involvement have been defined in order for the study to be launched on September 26, 2005 (with a 3-month recruitment period) and end July 2006. The primary analysis will provide an overall estimate of costs per ischemic stroke patient. Sub-analyses for atrial fibrillation and severity will also be conducted. CONCLUSIONS: The BURST study will be the first Canadian study that will determine the resource utilization and overall costs of treating ischemic stroke in both acute and post-acute settings with participation from tertiary-based and community-based stroke centres. The economic data collected will be critical for future stroke care funding systems. 3 Leiden University Medical Center, Leiden, ZuidHolland, The Netherlands OBJECTIVES: To investigate how the choice of multicriteria decision method influences outcome (ranking criteria and criteria weights). Population. A convenience sample of 28 subjects, 12 healthy and 16 cognitively impaired. METHODS: Based on a literature review, 5 multicriteria methods were chosen for comparison including: Kepner-tregoe analysis (KTA), simple multi attribute rating technique (SMART), SMART using swing weights (SWING), Analytic Hierarchy Process (AHP) and Conjoint Analysis (CA). Four attributes of treatment were identified (impact, duration, and end-result of treatment and associated risks). Subjects were asked to both rank and rate the importance of these attributes with each method. The order of methods was randomized and the total length of the interview was restricted to one hour. Some subjects therefore did not use all methods. Subjects were interviewed either once (n = 14) or twice (n = 14) (Only the results of the first measurement are presented) RESULTS: The highest percentages of rank reversals were found between CA and other methods (55-62%). The lowest percentage of rank reversals was between KTA and SMART (18%). The percentage of rank reversals was significantly higher in impaired population (An average of 54% compared to 36% in unimpaired population). When comparing actual weights, AHP and SMART correlate highly with all other methods except CA. CONCLU-SIONS: The high percentages in rank reversal and divergent correlation between individual weights (especially CA compared to other methods) show that the method chosen influences outcome. This has to be taken into account when the ranks or weights are used in multi-criteria decision analysis to make actual treatment decisions. The dissimilar methodology of CA might explain the high percentages of rank-reversals and low correlation between this method and other. Also, the design of the survey might have influenced CA weights and ranking.
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